SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections
Published inStroke, vol. 51, no. 12, p. 3523-3530
Publication date2020-12
First online date2020-11-09
Abstract
Keywords
- ROC curve
- Biomarkers
- Cohort studies
- Infections
- Serum amyloid A protein
- Aged
- Aged, 80 and over
- Area Under Curve
- C-Reactive Protein / metabolism
- Clinical Decision Rules
- Cross Infection / epidemiology
- Cross Infection / metabolism
- Deglutition Disorders / physiopathology
- Female
- Healthcare-Associated Pneumonia / epidemiology
- Healthcare-Associated Pneumonia / metabolism
- Humans
- Ischemic Stroke / metabolism
- Ischemic Stroke / physiopathology
- Ischemic Stroke / therapy
- Leukocyte Count
- Logistic Models
- Male
- Middle Aged
- Procalcitonin / metabolism
- ROC Curve
- Reproducibility of Results
- Sepsis / metabolism
- Sepsis / physiopathology
- Sepsis / therapy
- Serum Amyloid A Protein / metabolism
- Urinary Tract Infections / metabolism
- Urinary Tract Infections / physiopathology
- Urinary Tract Infections / therapy
Affiliation
Research group
Citation (ISO format)
SCHWEIZER, Juliane et al. SAA (Serum Amyloid A): A Novel Predictor of Stroke-Associated Infections. In: Stroke, 2020, vol. 51, n° 12, p. 3523–3530. doi: 10.1161/STROKEAHA.120.030064
Main files (1)
Article (Published version)
Identifiers
- PID : unige:162921
- DOI : 10.1161/STROKEAHA.120.030064
- PMID : 33161846
ISSN of the journal0039-2499